# Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

> **NCT02103361** · — · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 200 (estimated)

## Conditions studied

- Psoriasis
- Pregnancy
- Psoriatic Arthritis
- Crohn Disease

## Interventions

- **DRUG:** Ustekinumab
- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT02103361
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2013-11
- **Primary completion:** 2030-05
- **Final completion:** 2031-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103361, "Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02103361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*